Table 3.
Strategy | Respondents (%) |
|
---|---|---|
Consumers | Producers | |
Public disclosure | 81 | 77 |
Peer review | 86 | 87 |
Auditing of content | 85 | 83 |
Alternative views presented | 91 | 88 |
Restrictions on presenters | 58 | 54 |
Abbreviation: ASCO, American Society of Clinical Oncology; COI, conflict of interest.
Effective to extremely effective.